With FDA orphan drug approval secured, Amal and his team are preparing for phase 1 clinical trials of their small-molecule drugs in 2026.
With FDA orphan drug approval secured, Amal and his team are preparing for phase 1 clinical trials of their small-molecule drugs in 2026.
Fabrication of microlasers using all edible components.
Doppler cloak confuses radars by altering the phase of incoming radar waves in real time.
The effects of aging on the human brain could be slowed down with the help of artificial intelligence.
Low-loss router based on an interferometer preserves polarization while directing single photons and entangled pairs.
Cell-laden hydrogels could promote tissue regeneration while avoiding immune rejection.
The world’s most grown legume could be used to make the batteries of the future.
Extra dimensions at the microscale could be tested experimentally within 3-5 years.
Sleep deprivation alters immune cell metabolism, causing changes to epigenetics through lactylation, triggering immune dysregulation.
Edible electronics from non-toxic materials enable complex ingestible devices for healthcare and food monitoring.